Neolapa 250mg Lapatinib Tablet

Link Copied
2,800.00

10 Vial (MOQ)

Business Type Exporter, Supplier
Packaging Type Vial
Composition Lapatinib
Packaging Size 30 Tablets
Click to view more

Product Details

Brand Name
Neolapa
Form
Tablet
Application
HER2+ Breast Cancer
Strength
250 Mg

Neolapa 250mg Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor-2.

 

The common side effects that are likely to occur while you are on the treatment with Neolapa 250mg Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.

 

Inform your healthcare provider at the first sign of diarrhea or dehydration. Monitor your blood pressure regularly while taking Neolapa 250mg Tablet. If you have diarrhea while taking this medication, drink plenty of fluids, eat low-fat, high-protein foods, and avoid milk and its products and herbal supplements.

Yes! I am interested

Looking for "Neolapa 250mg Lapatinib Tablet" ?

Vial

Explore More Products



Close

Raise your Query

Hi! Simply click below and type your query.

Our experts will reply you very soon.

WhatsApp Us